Results 151 to 160 of about 35,812 (218)

Epigenetic Derepression of PROX1 Promotes Neuroendocrine Prostate Cancer Progression. [PDF]

Cancer Res
Venkadakrishnan VB, Presser A, Voss NCE, Neiswender J, Brenan L, Sosa KP, Weng K, Acosta AM, Vazquez F, Beltran H.   +9 more
europepmc   +1 more source

Crosstalk between EZH2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity. [PDF]

Nat Commun
Singh R, Venkadakrishnan VB, Imada E, Yamada Y, Brady NJ, Dunmore KE, Garner R, Booker MA, Hanratty B, Haffner MC, Tolstorukov MY, Marchionni L, Robinson BD, Rickman DS, Beltran H.   +14 more
europepmc   +1 more source

Unexpected brain metastases from neuroendocrine prostate cancer detected by [¹⁸F]fluorocholine PET/CT: a case report. [PDF]

Front Med (Lausanne)
Benameur Y, Hommadi M, Sahel OA, Oueriagli SN, Zahfir I, Aboussabr M, Bakkali JE, Doudouh A.   +7 more
europepmc   +1 more source

Phase 2 study of talabostat, a small molecule inhibitor of dipeptidyl peptidases (DPP), administered in combination with pembrolizumab in patients with small cell neuroendocrine prostate cancer. [PDF]

J Immunother Cancer
Aggarwal R, Zhang J, Monk P, Zhu X, Jones R, Linch M, Costin D, de Bono J, Karsh LI, Petrylak DP, Zhang L, Deshpande R, Borderies P, Huang J, O'Neill V, Donkor M, Tagawa S.   +16 more
europepmc   +1 more source

Patent Foramen Ovale Closure in Neuroendocrine Prostate Cancer-Induced Hepatopulmonary Syndrome: Fruitful or Futile? [PDF]

JACC Case Rep
D'Costa ZU, Qadir N, Parikh RV, Aboulhosn JA, Li A, Shen J, Riahi I, Du AX, Yang EH.   +8 more
europepmc   +1 more source

Glypican-3 as a Radiotheranostic Target for Neuroendocrine Prostate Cancer. [PDF]

Eur Urol
Lee W, Chung JY, Baidoo KE, Nambiar D, Basuli F, Coleman I, Bakht M, Li C, Shin J, Jeong SU, Cho YM, Beltran H, Nelson PS, Sowalsky AG, Choyke PL, Escorcia FE.   +15 more
europepmc   +1 more source

The Quartet of Core Oncogenic Drivers in Neuroendocrine Prostate Cancer: Multi-Omics Dataset Integration to Forge a Translational Link Between Biology and Precision Therapy. [PDF]

Int J Biol Sci
Wang Y, Wu N, Li J, Cao Q, Ye J, Zhang S.   +5 more
europepmc   +1 more source

A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer. [PDF]

Neoplasia
Dung PVT, Chen WY, Liu MK, Yeh SD, Kajla G, Yeh HL, Chen WH, Jiang KC, Li HR, Chen CS, Beltran H, Wen YC, Liu YN.   +12 more
europepmc   +1 more source

The Olive Phenolic <i>S</i>-(-)-Hydroxyoleocanthal Attenuates Neuroendocrine Prostate Cancer via Modulation of EPHA3-Centered Oncogenic Network. [PDF]

Cancers (Basel)
Tarun MTI, Ebrahim HY, El Sayed KA.
europepmc   +1 more source